Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase
- PMID: 9126968
Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase
Abstract
IL-6 is a multifunctional cytokine involved in hemopoiesis, immune regulation, inflammation, neural development, and infection. IL-6 belongs to a family of related cytokines that includes leukemia inhibitory factor, oncostatin M, IL-11, ciliary neurotropic factor, and cardiotropin-1, all of which initiate signaling through a receptor-associated gp130. IL-6 induces homodimerization of gp130 and activates the Jak/STAT pathway of signal transduction. In addition, IL-6 stimulates the mitogen-activated protein kinases designated ERK (extracellular signal-regulated kinase)-1 and -2. Activation of ERK-1 and -2 may involve the Src homology-2 containing proteins Shc and Grb2. Here we provide evidence that Shc could function as signaling molecules for IL-6 in DeFew-IL-6R/gp130 cells, a human B lymphoma cell line engineered to express high levels of both the IL-6R (p80) and the gp130 subunit. IL-6 was shown to promote the rapid tyrosine phosphorylation of gp130, Jak2, and Shc proteins. Moreover, Shc associated both in vivo and in vitro with phosphorylated gp130 through the Shc-Src homology-2 domain. We also report that Shc bound to activated Jak2 by using the Shc amino terminal phosphotyrosine interaction domain. Following IL-6 stimulation, Shc physically associated with Grb2. Thus, the data point to Shc proteins as a functional link between the Jak2 and Ras pathways of IL-6 signal transduction.
Similar articles
-
Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.Biochem J. 1998 Nov 1;335 ( Pt 3)(Pt 3):557-65. doi: 10.1042/bj3350557. Biochem J. 1998. PMID: 9794795 Free PMC article.
-
Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.Mol Cell Biol. 1999 Aug;19(8):5326-38. doi: 10.1128/MCB.19.8.5326. Mol Cell Biol. 1999. PMID: 10409724 Free PMC article.
-
IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.J Immunol. 1997 Sep 1;159(5):2212-21. J Immunol. 1997. PMID: 9278309
-
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.Biochem J. 1998 Sep 1;334 ( Pt 2)(Pt 2):297-314. doi: 10.1042/bj3340297. Biochem J. 1998. PMID: 9716487 Free PMC article. Review.
-
CSF-1 signal transduction.J Leukoc Biol. 1997 Aug;62(2):145-55. doi: 10.1002/jlb.62.2.145. J Leukoc Biol. 1997. PMID: 9261328 Review.
Cited by
-
Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?Ann N Y Acad Sci. 2009 Aug;1171:59-76. doi: 10.1111/j.1749-6632.2009.04911.x. Ann N Y Acad Sci. 2009. PMID: 19723038 Free PMC article. Review.
-
The STAT3 beacon: IL-6 recurrently activates STAT 3 from endosomal structures.Exp Cell Res. 2011 Aug 15;317(14):1955-69. doi: 10.1016/j.yexcr.2011.05.009. Epub 2011 May 18. Exp Cell Res. 2011. PMID: 21619877 Free PMC article.
-
Infection-induced IL-10 and JAK-STAT: A review of the molecular circuitry controlling immune hyperactivity in response to pathogenic microbes.JAKSTAT. 2012 Jul 1;1(3):159-67. doi: 10.4161/jkst.19918. JAKSTAT. 2012. PMID: 24058765 Free PMC article. Review.
-
Peptide-guided targeting of GPR55 for anti-cancer therapy.Oncotarget. 2017 Jan 17;8(3):5179-5195. doi: 10.18632/oncotarget.14121. Oncotarget. 2017. PMID: 28029647 Free PMC article.
-
Grb2 Induces Cardiorenal Syndrome Type 3: Roles of IL-6, Cardiomyocyte Bioenergetics, and Akt/mTOR Pathway.Front Cell Dev Biol. 2021 Mar 22;9:630412. doi: 10.3389/fcell.2021.630412. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33829014 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous